Rate My Professor Alf Garcia-Bennett

In December 2015, Garcia-Bennett was awarded an ARC Future Fellowship to investigate nanoparticle-protein interactions. In 2021, he became Research Director of the ARC Industrial Transformation Training Centre for Facilitated Advancement of Australia's Bioactives (FAAB), a consortium of four universities and thirteen partner organizations led by Professors Alison Rodger and Anwar Sunna. He is also the co-founder of Nanologica AB, established in Stockholm in 2004, which commercializes mesoporous materials as drug delivery vehicles and separation media in the pharmaceutical sector. His research focuses on mesoporous materials, exploring how their intrinsic physicochemical properties translate into biological effects through interactions with physiological proteins. Techniques employed include transmission and scanning electron microscopy, gas adsorption, and X-ray diffraction. Garcia-Bennett has supervised four PhD theses and boasts an h-index of 31 with 4,474 citations across 90 research outputs. Notable publications include 'High-pressure homogenization enhances the physicochemical properties and extraction of broccoli leaf bioactives' (2026, Food Chemistry), 'Post-normal bioactives: reframing food, health, and sustainability' (2026, Trends in Food Science & Technology), 'SANS/SAXS study to unravel the protein corona dynamics using deuterated human serum albumin interactions with plasmonic Au nanostructures' (2025, ACS Applied Nano Materials), and 'A unique insight into the defect structures of bicontinuous mesoporous silica using three-dimensional electron diffraction' (2020, IUCrJ). He serves as Chief Investigator on projects such as FAAB and the Biomolecular Discovery and Design Research Centre.